SCHEMBL4903216

SCHEMBL4903216

O=c1cc(Nc2ccc3[nH]cnc3c2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
CDK1 P06493 5/20 0.37
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
APEX1 P27695 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
QPCT Q16769 2/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
FBP1 P09467 1/20 0.34
EPHB2 P29323 1/20 0.34
MKNK1 Q9BUB5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923061 0.75 KDR (0.41) QPCTPOLBKDR
SCHEMBL2544215 0.74 CDK2 (0.46) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL5760871 0.73 QPCT (0.51) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL31036089 0.72 EGFR (0.43) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL21646358 0.72 ADRA2A (0.42) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL6625328 0.72 MAPT (0.47) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL4598414 0.72 POLB (0.52) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL4910893 0.72 ROCK1 (0.47) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL7185293 0.72 MAPT (0.53) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL18789600 0.71 ADRA2A (0.40) ADRA2AADRA2CADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 ADRA2A 4099/4885ADRA2C 4435/4885ADRA1D 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.